Simplifying Global Compliance
U.S. FDA Issues Guidances to Spur First-In-Human Studies
International Medical Device Regulatory Monitor
The U.S. Food and Drug Administration (FDA) proposes to streamline device clinical trials in a pair of draft guidances outlining requirements for early feasibility studies and explaining when a trial can begin even when there are outstanding issues with an Investigational Device Exemption (IDE) submission.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing